Skip to main content

Living Smart Blog

Cancer

NEW: Prostate Screening Guidelines

Key Takeaways:

  • There’s been an increase in men diagnosed with late-stage prostate cancer
  • The American Cancer Society has updated its prostate cancer screening guidelines with a particular focus on Black men and men with a family history of the disease to start annual screening at 45 until at least 69.
  • Men of average risk should do screening every two years between ages 50 to 69.
  • Recommended screening is a PSA blood test. Prostate-Specific Antigen (PSA) is a protein made by normal and cancerous cells in the prostate gland.
  • Controllable risk factors associated with prostate cancer include eating a healthy diet, regular exercise, avoiding smoking and alcohol intake and maintain a healthy weight.

Black men and all men with a family history of prostate cancer now encouraged to start annual screening at 45, according to new guidelines from American Cancer Society

For the last 20 years, there’s been an increasing trend with men and prostate cancer. Unfortunately, it’s not going in the right direction.

More and more men, particularly African-American males and men with a family history of prostate cancer, are being diagnosed with late-stage disease. We’re seeing about a three percent increase per year in diagnoses in the United States, says Dr. Leonard Henry, St. Joseph’s/Candler surgical oncologist and medical director of the Nancy N. and J.C. Lewis Cancer & Research Pavilion.

That’s why just last week the American Cancer Society updated its prostate cancer screening guidelines to help diagnosis the disease before it spreads and reduce the risk of dying.

“Recent studies show prostate cancer screening has demonstrated a mortality reduction, meaning screening can potentially save men from dying of prostate cancer,” Dr. Henry says. “That hasn’t always been clear in the past.”

Related Article: You’ve been diagnosed with prostate cancer. Now what?

Dr. Henry Leonard, St. Joseph's/Candler surgical oncologist

What has changed?

Updated recommendations for prostate cancer, according to the American Cancer Society, include:

  • PSA (Prostate-Specific Antigen) screening every two years for average-risk men aged 50 to 69.
  • Men at high risk, including African-Americans and non-Black men with a strong family history of prostate cancer – meaning a first-degree relative diagnosed before 65 or multiple first-degree relatives diagnosed at any age – should be screened annually from ages 45 to 69.
  • Non-African-American males with a single first-degree relative diagnosed at age 65 or older should be screened every two years starting at 45 until 69.
  • Individualized decision making on continuing screening is recommended for men ages 70 to 74.
  • Men with elevated PSA levels should undergo repeated PSA testing between two weeks and three months.
  • Screening is not recommended for men 75 to 79, but should still be discussed with a healthcare provider based on your individualized needs.
  • Screening is not recommended for men aged 80 and older and for men who are not expected to live another 10 years.

“These new guidelines are issued in part because there are ways now to mitigate the risks of causing excessive biopsies, over-diagnosing prostate cancer and over-treating it,” Dr. Henry says. “There’s retesting. There’s confirmatory testing. MRI prostate scans are becoming more readily available, and then there’s active surveillance of low-risk cancers. So, some of the harms associated with screening have now been reduced. According to the rigorous statistically modelling completed, the American Cancer Society now concludes that the risk-benefit ratio favors prostate cancer screening.”

About prostate cancer

Prostate cancer is often a slow-growing disease that begins when cells in the prostate gland start to grow out of control. About one in eight men will be diagnosed with prostate cancer in their lifetime, Dr. Henry says.

Prostate cancer is the second leading cause of cancer death in American men – behind lung cancer – with about one man out of 50 dying from the disease.

As you get older, the chances you may get prostate cancer increase. The average age of men who are first diagnosed with prostate cancer is 67.

Other risk factors can include race and ethnicity and a family history of not just prostate cancer but also breast cancer due to the BRAC2 gene mutation.

Related Article: What to expect if your prostate cancer requires surgery

About PSA testing

A prostate screening typically includes a PSA blood test. Prostate-Specific Antigen (PSA) is a protein made by normal and cancerous cells in the prostate gland. A blood test can help determine a patient’s PSA level (nanograms per milliliter or ng/mL).

“Historically major groups recommended against screening with PSA testing because of test variability, unclear mortality benefit and significant harms associated with unnecessary biopsies and over-treatment,” Dr. Henry says. “We are now observing an increase in late stage diagnosis. The risks of overdiagnosis and overtreatment have been mitigated. These new recommendations are far more specific and actionable.”

What can men do to lower their risk of prostate cancer?

Some of the risk factors associated with prostate cancer you can’t control, such as age, race and a family history, Dr. Henry says. However, a healthy lifestyle can reduce the risk of getting life-threatening prostate cancer by nearly 40 percent, he adds.

Healthy lifestyle tips include:

  • Maintaining a healthy weight
  • Never smoke or stop now
  • Limit or avoid alcohol use
  • Exercise regularly
  • Eat a healthy diet that is low in processed foods

“Primary care physicians are the experts on wellness and prevention so I’d recommend starting with your primary care physician about prostate cancer screening,” Dr. Henry says. “It’s a simple blood test. If you are seeing your doctor once a year, it’s very simple to add that blood test and get screened when appropriate for you.”

“If you are diagnosed with low-risk prostate cancer and it’s caught early and hasn’t spread, long-term survival rates are fantastic. It’s possible you may not even need treatment at all.”